Viewing StudyNCT01839487



Ignite Creation Date: 2024-05-06 @ 1:31 AM
Last Modification Date: 2024-10-26 @ 11:06 AM
Study NCT ID: NCT01839487
Status: COMPLETED
Last Update Posted: 2020-07-20
First Post: 2013-04-22

Brief Title: PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer
Sponsor:
Organization: Halozyme Therapeutics

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 279
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: